B2 bradykinin receptor — Drug Target

All drugs that target B2 bradykinin receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Bradykinin B2 Receptor Antagonist

Marketed (1)

• Firazyr · Takeda · Bradykinin B2 Receptor Antagonist · Neuroscience
  Firazyr works by blocking the action of bradykinin, a protein that causes blood vessels to swell and leads to symptoms of HAE.